2009Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Efficacy of Milinqing in Combination with Terazosin for IIIB Type Prostatitis

Wen Zhang

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe the clinical efficacy of Milinqing in combination with terazosin for ⅢB type prostatitis.METHODS:60 cases met the criteria of ⅢB type prostatitis were enrolled.All patients were treated with Milinqing(3 capsules/time,tid.)plus terazosin(2 mg q.d)for 6 weeks.The curative efficacy was compared between the two groups with NIH-CPSI scores as index.RESULTS:The total NIH-CPSI scores were 25.3±1.9 before treatment vs.10.9±1.2 after treatment(P0.01);the NIH-CPSI scores for pain and discomfort were 13.9±1.4 before treatment vs.6.9±1.2 after treatment(P0.05);and the NIH-CPSI scores for urination symptoms were 6.0±1.1 vs.1.1±0.5(P0.05);and the scores for quality of life were 6.9±0.9 vs.1.8±0.6(P0.01).CONCLUSION:Treatment of ⅢB type prostatitis with Milinqing in combination with terazosin achieved satisfactory curative efficacy.

About this research paper

What this paper is about

OBJECTIVE:To observe the clinical efficacy of Milinqing in combination with terazosin for ⅢB type prostatitis.METHODS:60 cases met the criteria of ⅢB type prostatitis were enrolled.All patients were treated with Milinqing(3 capsules/time,tid.)plus terazosin(2 mg q.d)for 6 weeks.The curative efficacy was compared between the two groups with NIH-CPSI scores as index.RESULTS:The total NIH-CPSI scores were 25.3±1.9 before treatment vs.10.9±1.2 after treatment(P0.01);the NIH-CPSI scores for pain and discomfort were 13.9±1.4 before treatment vs.6.9±1.2 after treatment(P0.05);and the NIH-CPSI scores for urination symptoms were 6.0±1.1 vs.1.1±0.5(P0.05);and the scores for quality of life were 6.9±0.9 vs.1.8±0.6(P0.01).CONCLUSION:Treatment of ⅢB type prostatitis with Milinqing in combination with terazosin achieved satisfactory curative efficacy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the clinical efficacy of Milinqing in combination with terazosin for ⅢB type prostatitis.METHODS:60 cases met the criteria of ⅢB type prostatitis were enrolled.All patients were treated with Milinqing(3 capsules/time,tid.)plus terazosin(2 mg q.d)for 6 weeks.The curative efficacy was compared between the two groups with NIH-CPSI scores as index.RESULTS:The total NIH-CPSI scores were 25.3±1.9 before treatment vs.10.9±1.2 after treatment(P0.01);the NIH-CPSI scores for pain and discomfort were 13.9±1.4 before treatment vs.6.9±1.2 after treatment(P0.05);and the NIH-CPSI scores for urination symptoms were 6.0±1.1 vs.1.1±0.5(P0.05);and the scores for quality of life were 6.9±0.9 vs.1.8±0.6(P0.01).CONCLUSION:Treatment of ⅢB type prostatitis with Milinqing in combination with terazosin achieved satisfactory curative efficacy.

Key concepts: Terazosin, Prostatitis, Medicine, Urology, Urination, Quality of life (healthcare), Combination therapy, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of Milinqing in Combination with Terazosin for IIIB Type Prostatitis — Research Paper | ScholarLens